Model
Edge
Alnylam Pharmaceuticals, Inc.
0001219016
Filing Type
4
Filing Date
5/18/2025
Updated
5/19/25, 2:17 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership